Analytical Data
-
基因名
Serum Albumin/ALB
-
简介
The serum albumin/ALB protein has multiple binding abilities and can bind water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin, and drugs. Its main effects include regulating blood colloid osmotic pressure to achieve homeostasis. Serum Albumin/ALB Protein, Human (HEK293, Flag) is the recombinant human-derived Serum Albumin/ALB protein, expressed by HEK293, with C-Flag labeled tag.
- Application
-
别名
Albumin; ALB; Serum albumin; ANALBA; FDAH; PRO0883; PRO0903; PRO1341
-
种属
Human
-
表达系统
HEK293
-
标签
C-Flag
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P02768-1
-
表达区间
D25-L609
-
蛋白长度
Full Length of Isoform-1 Mature Protein
-
分子量
65-70 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Serum albumin, primarily produced by the liver, is the most abundant protein in human plasma and plays a crucial role in maintaining oncotic pressure, transporting various molecules, and acting as a reservoir for hormones and drugs. Research into recombinant human serum albumin (rHSA) has gained significant attention due to its potential therapeutic applications and advantages over traditional plasma-derived albumin. The production of rHSA offers a safer alternative, eliminating risks related to bloodborne pathogens, while also allowing for large-scale production and purification in controlled environments. Furthermore, rHSA can be engineered for enhanced stability and extended half-life, providing improved efficacy for drug delivery systems. Studies have demonstrated its use in various clinical settings, including liver disease, critical care, and as a carrier for therapeutics in cancer treatment. Recent advancements in biotechnology, such as genetic engineering and novel expression systems, have facilitated the development of rHSA with superior properties, leading to an increased interest in its application in medicine. Investigating the structure-function relationship of rHSA is essential for optimizing its performance and understanding its interaction with other biomolecules. As the demand for safer and more efficient therapeutics continues to rise, rHSA remains a pivotal focus in both academic and industrial research, promising to revolutionize treatment protocols and improve patient outcomes in the future.
